118-41-2
118-41-2
Chemical Structure
3,4,5-Trimethoxybenzoic acid
Synonym(s): Eudesmic acid; Trimethylgallic Acid
- CAS No.: 118-41-2
- Formula:C10H12O5
- Molecular Weight:212.20
IUPAC Name: 3,4,5-trimethoxybenzoic acid
InChIKey: SJSOFNCYXJUNBT-UHFFFAOYSA-N
SMILES: O=C(O)C1=CC(OC)=C(OC)C(OC)=C1
Biological Activity: 3,4,5-Trimethoxybenzoic acid (Eudesmic acid;Trimethylgallic Acid) is a benzoic acid derivative. A building block in medicine and organic synthesis. 3,4,5-Trimethoxybenzoic acid exhibits antibacterial activity against S. aureus with MIC of 0.97 μg/mL[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3,4,5-Trimethoxybenzoic acid | 99.90% | 3,4,5-Trimethoxybenzoic acid (Eudesmic acid;Trimethylgallic Acid) is a benzoic acid derivative. A building block in medicine and organic synthesis. 3,4,5-Trimethoxybenzoic acid exhibits antibacterial activity against S. aureus with MIC of 0.97 μg/mL. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3,4,5-Trimethoxybenzoic acid (Standard) | ≥98% | 3,4,5-Trimethoxybenzoic acid (Eudesmic acid;Trimethylgallic Acid) is a benzoic acid derivative. A building block in medicine and organic synthesis. 3,4,5-Trimethoxybenzoic acid exhibits antibacterial activity against S. aureus with MIC of 0.97 μg/mL. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3,4,5-Trimethoxybenzoic acid-d3 | 3,4,5-Trimethoxybenzoic acid-d3 is the deuterium labeled 3,4,5-Trimethoxybenzoic acid. 3,4,5-Trimethoxybenzoic acid (Eudesmic acid;Trimethylgallic Acid) is a benzoic acid derivative. A building block in medicine and organic synthesis. 3,4,5-Trimethoxybenzoic acid exhibits antibacterial activity against S. aureus with MIC of 0.97 μg/mL. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methyl 4-amino-2,6-dimethoxybenzoate | 99.56% | Methyl 4-amino-2,6-dimethoxybenzoate is a drug intermediate for synthesis of various active compounds. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Syringic acid | 99.58% | Syringic acid is correlated with high antioxidant activity and inhibition of LDL oxidation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Veratric acid | 99.93% | Veratric acid (3,4-Dimethoxybenzoic acid) is an orally active phenolic compound derived from vegetables and fruits, has antioxidant and anti-inflammatory activities. Veratric acid also acts as a protective agent against hypertension-associated cardiovascular remodelling. Veratric acid reduces upregulated COX-2 expression, and levels of PGE2, IL-6 after UVB irradiation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methyl 3-hydroxy-4,5-dimethoxybenzoate | 98.10% | Methyl 3-hydroxy-4,5-dimethoxybenzoate is a gallic acid derivant that can be isolated from myricaria Laxiflora. Methyl 3-hydroxy-4,5-dimethoxybenzoate shows obvious antimicrobial activities. Methyl 3-hydroxy-4,5-dimethoxybenzoate shows fairly active for oxidation resistance in the presence of H2O2. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methyl syringate (Standard) | ≥98% | Methyl syringate is a selective TRPA1 agonist. Methyl syringate regulates food intake and gastric emptying through a TRPA1-mediated pathway. Methyl syringate is an efficient phenolic mediator for bacterial and fungal laccases. Methyl syringate is a chemical marker of Asphodel monofloral honey. Methyl syringate contributes to the antibacterial activity of honey. Methyl syringate inhibits aflatoxin production. Methyl syringate can contribute to weight suppression. Methyl syringate can be studies for cancer prevention (e.g. lung cancer), suppression of hypoxia-induced inflammatory response and tumorigenesis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Acetosyringone (Standard) | ≥98% | Acetosyringone (Standard) is the analytical standard of Acetosyringone. This product is intended for research and analytical applications. Acetosyringone is a phenolic compound from wounded plant cells, enables virA gene which encodes a membrane-bound kinase to phosphorylate itself and activate the virG gene product, which stimulates the transcription of other vir genes and itself. Acetosyringone enhances efficient Dunaliella transformation of Agrobacterium strains. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3,4,5-Trimethoxybenzaldehyde | 99.80% | 3,4,5-Trimethoxybenzaldehyde is a derivative of benzaldehyde. 3,4,5-Trimethoxybenzaldehyde has antimicrobial activity. 3,4,5-Trimethoxybenzaldehyde is also an important intermediate for the synthesis of various drugs, such as Trimethoprim (HY-B0510). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Antiarol | 99.98% | Antiarol (3,4,5-Trimethoxyphenol) is a phenolic compound present in the trunk of Coffea canephora. Antiarol is a metabolite produced by chicken cecal microbes, whose cecal content changes dynamically with the severity of wooden breast (WB; a muscle disease prevalent in broilers) and enters the plasma through circulation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Veratric acid-13C | Veratric acid-13C (3,4-Dimethoxybenzoic acid-13C) is the 13C-labeled Veratric acid (HY-N2007). Veratric acid (3,4-Dimethoxybenzoic acid) is an orally active phenolic compound derived from vegetables and fruits, has antioxidant and anti-inflammatory activities. Veratric acid also acts as a protective agent against hypertension-associated cardiovascular remodelling. Veratric acid reduces upregulated COX-2 expression, and levels of PGE2, IL-6 after UVB irradiation. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2,4,5-Trimethoxybenzoic acid | 99.98% | 2,4,5-Trimethoxybenzoic acid (Asaronic acid) is a compound identified in purple perilla extracts. 2,4,5-Trimethoxybenzoic acid inhibits LPS (HY-D1056)-induced inflammatory responses, inhibits the activation of NF-κB and STAT signaling pathways. 2,4,5-Trimethoxybenzoic acid inhibits M1 macrophage phenotype-mediated inflammation in diabetes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Kolev I, et al. Further findings concerning 2, 6-diiodo-3, 4, 5-trimethoxybenzoic acid (Part II)[J]. Journal of Molecular Structure, 2023, 1294: 136388.
- [2]. Bisignano G, et al., Antimicrobial activity of Mitracarpus scaber extract and isolated constituents. Lett Appl Microbiol. 2000 Feb;30(2):105-8. [Content Brief]
